Prandin

Active Ingredient(s): Repaglinide
FDA Approved: * December 22, 1997
Pharm Company: * NOVO NORDISK INC
Category: Diabetes

Repaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983. Repaglinide is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus.[1] The mechanism of action of repaglinide involves promoting insulin release from β-islet cells of the pancreas; like other antidiabetic drugs, a main side effect concern is hypoglycemia.[1] It is sold by Novo Nordisk unde... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Prandin
Prandin 0.5 mg Oral Tablet
NDC: 0169-0081
Labeler:
Novo Nordisk
Prandin
Prandin 1 mg Oral Tablet
NDC: 0169-0082
Labeler:
Novo Nordisk
Prandin
Prandin 2 mg Oral Tablet
NDC: 0169-0084
Labeler:
Novo Nordisk
Prandin 0.5 mg Oral Tablet
NDC: 35356-303
Labeler:
Lake Erie Medical Dba Quality Care Products LLC
Prandin 2 mg Oral Tablet
NDC: 49349-559
Labeler:
Remedyrepack Inc.
Prandin 2 mg Oral Tablet
NDC: 54868-5381
Labeler:
Physicians Total Care, Inc.
Prandin 1 mg Oral Tablet
NDC: 54868-6439
Labeler:
Physicians Total Care, Inc.
Prandin 1 mg Oral Tablet
NDC: 55154-4575
Labeler:
Cardinal Health
Prandin 1 mg/mg Oral Pill
NDC: 60846-882
Labeler:
Gemini Laboratories, LLC
Prandin 2 mg/mg Oral Pill
NDC: 60846-884
Labeler:
Gemini Laboratories, LLC

Related Brands

Drugs with the same active ingredients